Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,298) with videos related to
Page
of 130
Sort By:
The Journal of Clinical Investigation
|
February 24, 2015
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, et al.
Cancer Research
|
May 18, 2017
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
Hengyu Lu, Nicole Villafane, Turgut Dogruluk, et al.
BMC Cancer
|
July 18, 2018
AKT isoform-specific expression and activation across cancer lineages
Jue Wang, Wei Zhao, Huifang Guo, et al.
The Journal of Experimental Medicine
|
November 26, 2021
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway
Ensong Guo, Rourou Xiao, Yifan Wu, et al.
Nature Communications
|
August 9, 2025
Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients
Travis W Moore, Elias Spiliotopoulos, Rowan L Callahan, et al.
Brain : a Journal of Neurology
|
September 9, 2016
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes
Emma S Reid, Apostolos Papandreou, Suzanne Drury, et al.
Molecular Cancer Therapeutics
|
February 4, 2010
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set
Eun Sung Park, Rosalia Rabinovsky, Mark Carey, et al.
Theranostics
|
July 30, 2020
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC
Seong-Jin Kim, Jin-Sung Ju, Myoung-Hee Kang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 5, 2025
ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer
Shen-Nan Shi, Qiuyang Xu, Zhiqi Liao, et al.
Annals of Surgical Oncology
|
September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival
Callisia N Clarke, Michael S Lee, Wei Wei, et al.
Page
of 130
Search research articles
Search
Showing results (1011-1020 of 1,298) with videos related to
Sort By:
Page
of 130
The Journal of Clinical Investigation
|
February 24, 2015
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, et al.
Cancer Research
|
May 18, 2017
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
Hengyu Lu, Nicole Villafane, Turgut Dogruluk, et al.
BMC Cancer
|
July 18, 2018
AKT isoform-specific expression and activation across cancer lineages
Jue Wang, Wei Zhao, Huifang Guo, et al.
The Journal of Experimental Medicine
|
November 26, 2021
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway
Ensong Guo, Rourou Xiao, Yifan Wu, et al.
Nature Communications
|
August 9, 2025
Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients
Travis W Moore, Elias Spiliotopoulos, Rowan L Callahan, et al.
Brain : a Journal of Neurology
|
September 9, 2016
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes
Emma S Reid, Apostolos Papandreou, Suzanne Drury, et al.
Molecular Cancer Therapeutics
|
February 4, 2010
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set
Eun Sung Park, Rosalia Rabinovsky, Mark Carey, et al.
Theranostics
|
July 30, 2020
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC
Seong-Jin Kim, Jin-Sung Ju, Myoung-Hee Kang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 5, 2025
ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer
Shen-Nan Shi, Qiuyang Xu, Zhiqi Liao, et al.
Annals of Surgical Oncology
|
September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival
Callisia N Clarke, Michael S Lee, Wei Wei, et al.
Page
of 130